ÂÜÀòÂÒÂ×

Philip Coblentz is an accomplished scientist with extensive experience in research roles focused on discovery biology and immunomodulatory drug discovery. Currently serving as an Associate Scientist at Corner Therapeutics since January 2022, Philip has previously held notable positions at Arrakis Therapeutics and Agenus, where significant contributions were made to discovery research. Philip's proficiency in laboratory techniques is underscored by a solid foundation in research at Boston Children's Hospital and the University of Florida, where investigations into lymphocyte responses and skeletal muscle biology were conducted. Academic credentials include dual Master's degrees in Human Performance and Exercise Physiology from the University of Florida and University of Miami, respectively, and a Bachelor's degree in Kinesiology and Exercise Science from the University of Maryland.